Delivery Order SPE2DR25D3304-SPE2DR26F48F8
- Not listed
- The Defense Logistics Agency awarded a $46,420.87 delivery order (Contract No. 4570345294) to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of December 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $36,136.31 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector units on December 5, 2025, with a completion deadline of December 8, 2025. This firm fixed-price delivery order represents a direct purchase of this specialty pharmaceutical product for use within federal medical supply chains. The contract was competitively awarded with no set-aside provisions, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a $24,463.76 delivery order (Contract No. 4570163223) to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child...
- The Defense Logistics Agency awarded a $52,670.24 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $31,401.85 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 21, 2025, with performance taking place at AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing among federal...
- The Defense Logistics Agency awarded a delivery order valued at $10,743.81 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,149.59 on January 2, 2026, for the supply of ENBREL 50 mg/ml SureClick auto-injectors, with completion scheduled for January 5, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger federal pharmaceutical supply vehicle. The contractor will perform the delivery from its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $11,380.41 delivery order (4570030232) to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of November 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a $39,049.72 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,543.12 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in...
- SPE2DR25D3304Indefinite Delivery Contract
- SPE2DR25D3304-SPE2DR26F48F8Delivery Order
The Defense Logistics Agency awarded a $17,987.02 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Enbrel 50 mg/mL SureClick prefilled auto-injectors. The contract utilizes firm fixed pricing with an ultimate completion date of January 6, 2026, and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime vendor contract enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. Enbrel, a TNF inhibitor used for rheumatoid arthritis and other autoimmune conditions, represents the type of specialty medication within the broad therapeutic portfolio that AmerisourceBergen delivers through its comprehensive federal contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 1/4/26 |